Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatesh Pilla-Reddy

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2022
Development of and insights from systems pharmacology models of antibody-drug conjugatesInez Lam, Venkatesh Pilla Reddy, Kathryn Ball, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 15, 2013
Modelling and simulation of placebo effect: application to drug development in schizophreniaVenkatesh Pilla Reddy, Magdalena Kozielska, Rik de Greef, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2018
An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling ApproachVenkatesh Pilla Reddy, Barry C Jones, Nicola Colclough, et al.
Frontiers in Pharmacology|June 23, 2022
Harnessing Clinical Trial and Real-World Data Towards an Understanding of Sex Effects on Drug Pharmacokinetics, Pharmacodynamics and EfficacyJoyce Oi Yan Chan, Marie Moullet, Beth Williamson, et al.
Clinical Pharmacology and Therapeutics|October 25, 2017
Harnessing Meta-analysis to Refine an Oncology Patient Population for Physiology-Based Pharmacokinetic Modeling of DrugsEmily Schwenger, Venkatesh Pilla Reddy, Ganesh Moorthy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2017
An Investigation into the Prediction of in Vivo Clearance for a Range of Flavin-containing Monooxygenase SubstratesBarry C Jones, Abhishek Srivastava, Nicola Colclough, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 30, 2022
Comparing the applications of machine learning, PBPK, and population pharmacokinetic models in pharmacokinetic drug-drug interaction predictionJaidip Gill, Marie Moullet, Anton Martinsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 16, 2022
Evaluating the performance of machine-learning regression models for pharmacokinetic drug-drug interactionsJaidip Gill, Marie Moullet, Anton Martinsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 5, 2025
Postmarketing Assessment of Antibody-Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index ApproachInnocent Gerald Asiimwe, Nour Chtiba, Samer Mouksassi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 7, 2020
A Laboratory-Specific Scaling Factor to Predict the In Vivo Human Clearance of Aldehyde Oxidase SubstratesMailys De Sousa Mendes, Alexandra L Orton, Helen E Humphries, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2022
Development of and insights from systems pharmacology models of antibody-drug conjugatesInez Lam, Venkatesh Pilla Reddy, Kathryn Ball, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 15, 2013
Modelling and simulation of placebo effect: application to drug development in schizophreniaVenkatesh Pilla Reddy, Magdalena Kozielska, Rik de Greef, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2018
An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling ApproachVenkatesh Pilla Reddy, Barry C Jones, Nicola Colclough, et al.
Frontiers in Pharmacology|June 23, 2022
Harnessing Clinical Trial and Real-World Data Towards an Understanding of Sex Effects on Drug Pharmacokinetics, Pharmacodynamics and EfficacyJoyce Oi Yan Chan, Marie Moullet, Beth Williamson, et al.
Clinical Pharmacology and Therapeutics|October 25, 2017
Harnessing Meta-analysis to Refine an Oncology Patient Population for Physiology-Based Pharmacokinetic Modeling of DrugsEmily Schwenger, Venkatesh Pilla Reddy, Ganesh Moorthy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2017
An Investigation into the Prediction of in Vivo Clearance for a Range of Flavin-containing Monooxygenase SubstratesBarry C Jones, Abhishek Srivastava, Nicola Colclough, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 30, 2022
Comparing the applications of machine learning, PBPK, and population pharmacokinetic models in pharmacokinetic drug-drug interaction predictionJaidip Gill, Marie Moullet, Anton Martinsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 16, 2022
Evaluating the performance of machine-learning regression models for pharmacokinetic drug-drug interactionsJaidip Gill, Marie Moullet, Anton Martinsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 5, 2025
Postmarketing Assessment of Antibody-Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index ApproachInnocent Gerald Asiimwe, Nour Chtiba, Samer Mouksassi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 7, 2020
A Laboratory-Specific Scaling Factor to Predict the In Vivo Human Clearance of Aldehyde Oxidase SubstratesMailys De Sousa Mendes, Alexandra L Orton, Helen E Humphries, et al.
Pageof 6